| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A case of abdominal wall percutaneous endoscopic gastrostomy site metastatic disease from primary oropharyngeal squamous cell carcinoma
|
Ayesa, S. L.
|
|
|
47 |
4 |
p. 1011-1012
|
artikel
|
| 2 |
An aggressive functioning pituitary adenoma treated with peptide receptor radionuclide therapy
|
Assadi, Majid
|
|
|
47 |
4 |
p. 1015-1016
|
artikel
|
| 3 |
Availability of both [177Lu]Lu-DOTA-TATE and [90Y]Y-DOTATATE as PRRT agents for neuroendocrine tumors: can we evolve a rational sequential duo-PRRT protocol for large volume resistant tumors?
|
Basu, Sandip
|
|
|
47 |
4 |
p. 756-758
|
artikel
|
| 4 |
Biodistribution and first clinical results of 18F-SiFAlin-TATE PET: a novel 18F-labeled somatostatin analog for imaging of neuroendocrine tumors
|
Ilhan, Harun
|
|
|
47 |
4 |
p. 870-880
|
artikel
|
| 5 |
Broadening horizons with 225Ac-DOTATATE targeted alpha therapy for gastroenteropancreatic neuroendocrine tumour patients stable or refractory to 177Lu-DOTATATE PRRT: first clinical experience on the efficacy and safety
|
Ballal, Sanjana
|
|
|
47 |
4 |
p. 934-946
|
artikel
|
| 6 |
Clinical quantification of the integrin αvβ6 by [18F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL Study)
|
Lukey, Pauline T.
|
|
|
47 |
4 |
p. 967-979
|
artikel
|
| 7 |
Combination treatments to enhance peptide receptor radionuclide therapy of neuroendocrine tumours
|
Adant, Samuel
|
|
|
47 |
4 |
p. 907-921
|
artikel
|
| 8 |
Comparative dosimetry between 99mTc-MAA SPECT/CT and 90Y PET/CT in primary and metastatic liver tumors
|
Jadoul, Alexandre
|
|
|
47 |
4 |
p. 828-837
|
artikel
|
| 9 |
Correction to: A multiparametric analysis based on DCE-MRI to improve the accuracy of parotid tumor discrimination
|
Xu, Zhifeng
|
|
|
47 |
4 |
p. 1017
|
artikel
|
| 10 |
Dose escalation of an Evans blue–modified radiolabeled somatostatin analog 177Lu-DOTA-EB-TATE in the treatment of metastatic neuroendocrine tumors
|
Liu, Qingxing
|
|
|
47 |
4 |
p. 947-957
|
artikel
|
| 11 |
Ethical principles for the application of artificial intelligence (AI) in nuclear medicine
|
Currie, Geoff
|
|
|
47 |
4 |
p. 748-752
|
artikel
|
| 12 |
Evaluation of [68Ga]Ga-DATA-TOC for imaging of neuroendocrine tumours: comparison with [68Ga]Ga-DOTA-NOC PET/CT
|
Yadav, Divya
|
|
|
47 |
4 |
p. 860-869
|
artikel
|
| 13 |
18F-FDG PET-MR enterography in predicting histological active disease using the Nancy index in ulcerative colitis: a randomized controlled trial
|
Li, Yan
|
|
|
47 |
4 |
p. 768-777
|
artikel
|
| 14 |
Granulomatous hepatitis masquerading as metastases on FDG PET/CT
|
Choudhury, Sayak
|
|
|
47 |
4 |
p. 1013-1014
|
artikel
|
| 15 |
166Ho microsphere scout dose for more accurate radioembolization treatment planning
|
Chiesa, C
|
|
|
47 |
4 |
p. 744-747
|
artikel
|
| 16 |
Hypoxia-induced modulation of glucose transporter expression impacts 18F-fluorodeoxyglucose PET-CT imaging in hepatocellular carcinoma
|
Xia, Hongping
|
|
|
47 |
4 |
p. 787-797
|
artikel
|
| 17 |
Incidental 18F-FDG uptake in the colon: value of contrast-enhanced CT correlation with colonoscopic findings
|
Kirchner, Julian
|
|
|
47 |
4 |
p. 778-786
|
artikel
|
| 18 |
Noninvasive PET tracking of post-transplant gut microbiota in living mice
|
Wang, Yanpu
|
|
|
47 |
4 |
p. 991-1002
|
artikel
|
| 19 |
Pathologist at the doorstep of cancer “I know your weaknesses and strength”: an interview with Jean Claude Reubi
|
Prasad, Vikas
|
|
|
47 |
4 |
p. 741-743
|
artikel
|
| 20 |
Preclinical evaluation of [18F]FB-A20FMDV2 as a selective marker for measuring αVβ6 integrin occupancy using positron emission tomography in rodent lung
|
Onega, Mayca
|
|
|
47 |
4 |
p. 958-966
|
artikel
|
| 21 |
Prognostic Significance of Somatostatin Receptor Heterogeneity in Progressive Neuroendocrine Tumor Treated with Lu-177 DOTATOC or Lu-177 DOTATATE
|
Graf, Josephine
|
|
|
47 |
4 |
p. 881-894
|
artikel
|
| 22 |
PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest
|
Bodei, Lisa
|
|
|
47 |
4 |
p. 895-906
|
artikel
|
| 23 |
Quantifying the effects of absorbed dose from radioembolisation on healthy liver function with [99mTc]TcMebrofenin
|
Willowson, Kathy P
|
|
|
47 |
4 |
p. 838-848
|
artikel
|
| 24 |
Safety and efficacy of radioembolization with glass microspheres in hepatocellular carcinoma patients with elevated lung shunt fraction: analysis of a 103-patient cohort
|
Das, Arighno
|
|
|
47 |
4 |
p. 807-815
|
artikel
|
| 25 |
Staging FDG PET-CT changes management in patients with gastric adenocarcinoma who are eligible for radical treatment
|
Bosch, Karen D.
|
|
|
47 |
4 |
p. 759-767
|
artikel
|
| 26 |
Tandem peptide receptor radionuclide therapy using 90Y/177Lu-DOTATATE for neuroendocrine tumors efficacy and side-effects - polish multicenter experience
|
Kunikowska, Jolanta
|
|
|
47 |
4 |
p. 922-933
|
artikel
|
| 27 |
The importance of differentiating between qualitative, semi-quantitative, and quantitative imaging—close only counts in horseshoes
|
Fleming, Richard M.
|
|
|
47 |
4 |
p. 753-755
|
artikel
|
| 28 |
The number of microspheres in Y90 radioembolization directly affects normal tissue radiation exposure
|
Pasciak, Alexander S.
|
|
|
47 |
4 |
p. 816-827
|
artikel
|
| 29 |
The radiosensitizer Onalespib increases complete remission in 177Lu-DOTATATE-treated mice bearing neuroendocrine tumor xenografts
|
Lundsten, Sara
|
|
|
47 |
4 |
p. 980-990
|
artikel
|
| 30 |
The superior predictive value of 166Ho-scout compared with 99mTc-macroaggregated albumin prior to 166Ho-microspheres radioembolization in patients with liver metastases
|
Smits, Maarten L. J.
|
|
|
47 |
4 |
p. 798-806
|
artikel
|
| 31 |
TOPKi-NBD: a fluorescent small molecule for tumor imaging
|
Pirovano, Giacomo
|
|
|
47 |
4 |
p. 1003-1010
|
artikel
|
| 32 |
[89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer
|
van Helden, E. J.
|
|
|
47 |
4 |
p. 849-859
|
artikel
|
Tijdschrift beschrijving